- Home
- SDOT vs CLDI Comparison
SDOT vs CLDI Comparison
Compare SDOT & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SDOT | CLDI |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2M | 3.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SDOT | CLDI |
|---|---|---|
| Price | $7.20 | $0.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.1M | 2.7M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 490.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,929,137.00 | N/A |
| Revenue This Year | $12.76 | N/A |
| Revenue Next Year | $5.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.08 | N/A |
| 52 Week Low | $0.14 | $0.12 |
| 52 Week High | $39.86 | $7.32 |
Technical Indicators
Market Signals| Indicator | SDOT | CLDI |
|---|---|---|
| Relative Strength Index (RSI) | 47.10 | 38.04 |
| Support Level | $2.45 | $0.12 |
| Resistance Level | $39.86 | $0.18 |
| Average True Range (ATR) | 10.34 | 0.01 |
| MACD | -1.27 | 0.00 |
| Stochastic Oscillator | 7.22 | 57.56 |
Price Performance
Historical ComparisonAbout SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.